SEC Company Response from ADVANCED NUTRACEUTICALS — Aug 11, 2005
ADVANCED NUTRACEUTICALS INC/TX (CIK 0000913614)
Date: Aug. 11, 2005 · CIK: 0000913614 · Accession: 0001047469-05-021379
AI Filing Summary & Sentiment
Letter
United States Securities and Exchange Commission Washington, D.C. 20549 Schedule TO-I (the "Filing") Filed July 26, 2005
RE:Advanced Nutraceuticals, Inc. ("ANI")
Dear Ms. Adams:
In connection with above-referenced filing, we hereby acknowledge that:
•ANI is responsible for the adequacy and accuracy of the disclosure in the Filing;
•Comments or changes to the disclosure in response to Staff comments reviewed by the Staff do not foreclose the Commission from taking any action with respect to the Filing; and
•ANI may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/
Gregory Pusey
Show Raw Text
CORRESP
1
filename1.htm
Advanced Nutraceuticals, Inc.
106 South University Boulevard, Unit 14
Denver, CO 80209
Abby
Adams
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE:Advanced
Nutraceuticals, Inc. ("ANI")
Schedule TO-I (the "Filing")
Filed July 26, 2005
Dear
Ms. Adams:
In
connection with above-referenced filing, we hereby acknowledge that:
•ANI
is responsible for the adequacy and accuracy of the disclosure in the Filing;
•Comments
or changes to the disclosure in response to Staff comments reviewed by the Staff do not foreclose the Commission from taking any action with respect to the Filing;
and
•ANI
may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/
Gregory Pusey
Gregory
Pusey
President and Chief Executive Officer